• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests

FDA Watch: MeMed and NG Biotech Receive FDA Breakthrough Device Designations for Rapid Infection Tests

by Ron Shinkman | Apr 14, 2026 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

In both cases, the diagnostic tests report results back within 15 minutes

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector

ADLM Calls on Feds to Regulate AI in the Clinical Lab Sector

by Ron Shinkman | Mar 27, 2026 | CDC-nir, CLIA-lca, CLIA-nir, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: Truvian Health Obtains 10 Additional FDA Clearances for TruVerus Platform

FDA Watch: Truvian Health Obtains 10 Additional FDA Clearances for TruVerus Platform

by Ron Shinkman | Feb 20, 2026 | FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

TruVerus is designed to perform a slew of clinical laboratory tests on as few as eight drops of blood

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk

Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk

by Ron Shinkman | Jan 26, 2026 | Clinical Diagnostics Insider, Testing Trends-dtet

The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: Truvian Health Receives Initial FDA Clearance for 34-Test Platform

FDA Watch: Truvian Health Receives Initial FDA Clearance for 34-Test Platform

by Ron Shinkman | Jan 26, 2026 | Essential, FDA-lca, FDA-lir, FDA-nir, Lab Industry Advisor

San Diego-based healthcare diagnostics company is trying to succeed where Theranos failed

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com